{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are currently recognized as the most common genetic cause of parkinsonism. Among the large number of LRRK2 mutations identified to date, the G2019S variant is the most common. In Asia, however, another LRRK2 variant, G2385R, appears to occur more frequently.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, indicating that LRRK2 mutations are a common cause of parkinsonism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Exposure to rotenone accelerates DA degeneration in LRRK2 G2019 and G2385R mutant flies.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (exposure to rotenone and assessment of DA degeneration) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Quantitative data are expressed as mean ± SEM, unless otherwise stated. Statistical significance for all the quantitative data obtained was analyzed using the Student's t test (*p < 0.05, **p < 0.001), unless otherwise stated.",
          "judgment": "No",
          "reasoning": "The paper does not provide explicit details on the use of variant controls (e.g., known pathogenic or benign variants) in the assay for this variant.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Exposure to rotenone accelerates DA degeneration in LRRK2 G2019 and G2385R mutant flies.",
          "judgment": "Yes",
          "reasoning": "The assay used (exposure to rotenone and assessment of DA degeneration) is a standard technique in the field and has been used in prior studies to assess Parkinson's disease-related pathogenesis.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant in LRRK2 is associated with accelerated DA degeneration upon rotenone exposure, supporting its pathogenic role in Parkinson's disease. However, the lack of explicit variant controls in the assay limits the strength of the evidence to PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "R",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are currently recognized as the most common genetic cause of parkinsonism. Among the large number of LRRK2 mutations identified to date, the G2019S variant is the most common. In Asia, however, another LRRK2 variant, G2385R, appears to occur more frequently.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, indicating that LRRK2 mutations are a common cause of parkinsonism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Exposure to rotenone accelerates DA degeneration in LRRK2 G2019 and G2385R mutant flies.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (exposure to rotenone and assessment of DA degeneration) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Quantitative data are expressed as mean ± SEM, unless otherwise stated. Statistical significance for all the quantitative data obtained was analyzed using the Student's t test (*p < 0.05, **p < 0.001), unless otherwise stated.",
          "judgment": "No",
          "reasoning": "The paper does not provide explicit details on the use of variant controls (e.g., known pathogenic or benign variants) in the assay for this variant.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Exposure to rotenone accelerates DA degeneration in LRRK2 G2019 and G2385R mutant flies.",
          "judgment": "Yes",
          "reasoning": "The assay used (exposure to rotenone and assessment of DA degeneration) is a standard technique in the field and has been used in prior studies to assess Parkinson's disease-related pathogenesis.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2385R variant in LRRK2 is associated with accelerated DA degeneration upon rotenone exposure, supporting its pathogenic role in Parkinson's disease. However, the lack of explicit variant controls in the assay limits the strength of the evidence to PS3_supporting."
    }
  ]
}